GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

China Health Group 8225.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.06

0.00%

Close of 5 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About China Health Group

Its shares trade on HKEX under the ticker 8225.HK. It has been listed since 10 July 2003. In the fiscal year to 31 December 2025, it reported revenue of CN¥27.8m and a net loss of CN¥14.6m. At that date it held total assets of CN¥87.1m and shareholders' equity of CN¥55.4m.

China Health Group, Inc. is an investment holding company, which provides drug discovery and development services. The company is headquartered in Beijing, Beijing. The company went IPO on 2003-07-10. The firm provides hospital clinical research and product promotion services, hospital management services, mobile telemedicine services, special expertise therapy services and rehabilitation and medical tours services. Its clinical research services include Phase I clinical and bioequivalence studies, Phase IV post-marketing clinical study, data management and medical statistics and medical administration-related services, among others. Its hospital management services include Internet healthcare services and drug delivery services, such as Chinese best doctor and My doctor 999, among others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Life Sciences Tools & Services
Listed since
10 Jul 2003
Employees
153

Leadership

Pay as last reported

  • Mr. Xia GuoExecutive Chairman of the Board, Chief Executive Officer, Joint Chief Technology Officer, Managing Director, since 2015HK$557,000
  • Mr. Liang LiFinancial Director
  • Dr. Tuo JinJoint Chief Technology Officer
  • Mr. Guo RaymondExecutive Director and Chief Artificial Intelligence Officer, since 2024
  • Dr. Tarun GuptaCo-Head - Business Development Department, International Division
  • Dr. Albert QinChief Medical Officer
  • Mr. Tsz Ngo YuJoint Company Secretary
  • Ms. Li ZhangNon-Executive Director
  • Mr. Tong GuoIndependent Non-Executive Director
  • Ms. Na LiuNon-Executive Independent Director
  • Dr. Bin Hui NiIndependent Non-Executive Director
  • Mr. Shuangsi WuNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • China Health Group Inc has several strengths that contribute to its success and competitiveness in the market. These include:

Weaknesses

  • Despite its strengths, China Health Group Inc also faces certain weaknesses that pose challenges and need to be addressed. These weaknesses include:

Opportunities

  • China Health Group Inc can leverage various opportunities in the market to drive growth and expand its business. These opportunities include:

Threats

  • China Health Group Inc should also be aware of potential threats in the market that could impact its business. These threats include:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.